ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA
Clinical trials for ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial aims to turn Patients' own cells against rare, aggressive cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new gene therapy for adults with certain T-cell lymphomas that have returned or not responded to prior treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to target a protein (CCR4) foun…
Matched conditions: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is the first study in people to test an experimental drug called DR-01 for adults with rare and aggressive blood cancers, including large granular lymphocytic leukemia (LGLL) and several types of cytotoxic lymphomas. The main goals are to find a safe dose and see if the drug…
Matched conditions: ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC